Altis Biosystems: Funding, Investors & Team (Aug 2026)
Altis Biosystems is a biotechnology company developing research tools for the pharma and biotech industries. The company has developed a patent-pending stem cell technology recreating the human intestinal epithelium for compound screening and microbiome research. Their organ on a chip product produces a layer of human or animal intestinal stem and differentiated cells, either of the small or large intestine. These cells can be used for disease modeling, precision medicine, microbiome research, and compound screening.
Altis Biosystems has raised $1.4M across 2 funding rounds on record, the most recent a Series A announced in Jan 2024.
Altis Biosystems Company Profile and Key Stats
Latest funding round on record: Jan 2024.
Altis Biosystems Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Altis Biosystems raised $1.4M in an undisclosed round announced in Aug 2022.
1.4 years later, a Series A was announced in Jan 2024 with no disclosed amount.
Altis Biosystems Founders and Leadership Team
Contact details for the Altis Biosystems team: 1 of 2 have an email address on file.
Start 14-day free trial →Altis Biosystems Funding Compared to Other Biotechnology Startups
Funded Startups Like Altis Biosystems in Biotechnology and Durham
Companies Similar to Altis Biosystems
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Altis Biosystems Funding FAQs
What does Altis Biosystems do?
Altis Biosystems is a biotechnology company developing research tools for the pharma and biotech industries. The company has developed a patent-pending stem cell technology recreating the human intestinal epithelium for compound screening and microbiome research. Their organ on a chip product produces a layer of human or animal intestinal stem and differentiated cells, either of the small or large intestine. These cells can be used for disease modeling, precision medicine, microbiome research, and compound screening.
How much funding has Altis Biosystems raised?
Altis Biosystems has raised $1.4M across 2 rounds on record.
When did Altis Biosystems last raise funding?
Altis Biosystems' most recent funding round on record was announced in Jan 2024. The amount was not disclosed.
Who founded Altis Biosystems?
FundedIQ lists Ben Scruggs (Founder) at Altis Biosystems.
Who is the CEO of Altis Biosystems?
Michael Biron is listed as CEO at Altis Biosystems.
Where is Altis Biosystems headquartered?
Altis Biosystems is based in Durham, North Carolina, United States.
How many employees does Altis Biosystems have?
Altis Biosystems is in the 11-50 employee band.
About FundedIQ's Altis Biosystems Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Altis Biosystems is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.